[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

Reed Elsevier Announces new CEO for Science & Medical



http://www.reedelsevier.com/index.cfm?articleid=962

Reed Elsevier announces appointment of Chief Executive Officer for Science 
& Medical Division
13 July 2004

Reed Elsevier Group plc today announced the appointment of Erik Engstrom
as chief executive officer of Elsevier, its global scientific and medical
publishing division.

Mr Engstrom will join the company in August 2004 and will be based in
Amsterdam.  He will be a main board director of Reed Elsevier Group plc
reporting to Sir Crispin Davis, Reed Elsevier's chief executive officer.

Mr Engstrom (41), who is Swedish, has been based in the US for the past 18
years.  He joins Reed Elsevier from General Atlantic Partners, a private
equity firm, where he was a general partner leading their media and
consumer investment sector since 2001.  Prior to that, Mr Engstrom had
extensive experience in the publishing sector as president and chief
operating officer of Random House Inc, the leading global consumer books
publishing business of Bertelsmann. He was also president and chief
executive officer of Bantam Doubleday Dell before its merger with Random
House.  Mr Engstrom began his business career as a consultant with
McKinsey after gaining his MBA from Harvard Business School where he was a
Fulbright Scholar.

Commenting on the announcement, Sir Crispin Davis said: �I am delighted to
welcome Erik to Reed Elsevier.  He is an exceptionally talented executive
with a consistent track record of success, wide international experience,
and extensive publishing expertise.  He will bring strong leadership to
the Elsevier business�.

On joining Reed Elsevier, Mr. Engstrom will be appointed to the Boards of
Reed Elsevier PLC and Reed Elsevier Group plc and will be put forward for
election to the Executive Board of Reed Elsevier NV at the annual general
meeting of that company in 2005.

-ends-

For further information please contact:
Susanna Smart, Reed Elsevier, tel +44 (0) 20 7166 5674